Wang Xiaodong's Form 4 filing
BeOne Medicines Ltd. (ONC) · filed Sep 10, 2026
- Accession no.
- 0001662982-26-000002
- Filed
- Sep 10, 2026, 4:49 PM ET
- Trade date
- Sep 8, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 9 non-derivative transactions and 1 derivative transaction. Open-market sales total $13.4M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wang XiaodongCIK 0001662982 | Director, Other: Chair, Scientific Advisory Brd |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | American Depositary Shares | SSaleDisposed | −1,181 | $345.38 | −$407,897.32 | 6,079 | Direct | |
| Sep 8, 2026 | American Depositary Shares | SSaleDisposed | −2,841 | $346.16 | −$983,433.46 | 3,238 | Direct | |
| Sep 8, 2026 | American Depositary Shares | SSaleDisposed | −1,517 | $347.39 | −$526,992.91 | 1,721 | Direct | |
| Sep 8, 2026 | American Depositary Shares | SSaleDisposed | −1,721 | $348.01 | −$598,929.68 | 0 | Direct | |
| Sep 8, 2026 | American Depositary Shares | MOption exerciseAcquired | +31,027 | $36.90 | +$1,144,896.3 | 31,027 | Direct | |
| Sep 8, 2026 | American Depositary Shares | SSaleDisposed | −7,492 | $348.31 | −$2,609,572.98 | 23,535 | Direct | |
| Sep 8, 2026 | American Depositary Shares | SSaleDisposed | −10,688 | $349.28 | −$3,733,140.98 | 12,847 | Direct | |
| Sep 8, 2026 | American Depositary Shares | SSaleDisposed | −6,569 | $350.27 | −$2,300,950.56 | 6,278 | Direct | |
| Sep 8, 2026 | American Depositary Shares | SSaleDisposed | −6,278 | $351.25 | −$2,205,173.87 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Ordinary Shares | MOption exerciseDisposed | −403,351 | $0.00 | $0 | 1,210,079 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.